---
title: Dabigatran for Treatment and Secondary Prevention of Venous Thromboembolism
  in Pediatric Congenital Heart Disease
date: '2024-02-13'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38348778/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240213170620&v=2.18.0
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: Data on favorable anticoagulant alternatives for the unmet
  needs of children with CHD are emerging, and our exploratory results suggest that
  dabigatran could be an appropriate treatment choice, although challenging sample
  size limitations in pediatric studies require cautious interpretation of ...'
disable_comments: true
---
CONCLUSIONS: Data on favorable anticoagulant alternatives for the unmet needs of children with CHD are emerging, and our exploratory results suggest that dabigatran could be an appropriate treatment choice, although challenging sample size limitations in pediatric studies require cautious interpretation of ...